Follow
Yue Wu
Yue Wu
School of Public Health, Faculty of Medicine and Health, University of Sydney
Verified email at sydney.edu.au
Title
Cited by
Cited by
Year
Implications of asymptomatic carriers for infectious disease transmission and control
RH Chisholm, PT Campbell, Y Wu, SYC Tong, J McVernon, N Geard
Royal Society open science 5 (2), 172341, 2018
752018
An economic case for a vaccine to prevent group A streptococcus skin infections
JW Cannon, S Jack, Y Wu, J Zhang, MG Baker, E Geelhoed, J Fraser, ...
Vaccine 36 (46), 6968-6978, 2018
422018
Dynamics of bacterial insertion sequences: can transposition bursts help the elements persist?
Y Wu, RZ Aandahl, MM Tanaka
BMC evolutionary biology 15 (1), 1-12, 2015
352015
Predicting the causative pathogen among children with osteomyelitis using Bayesian networks–improving antibiotic selection in clinical practice
Y Wu, C McLeod, C Blyth, A Bowen, A Martin, A Nicholson, S Mascaro, ...
Artificial Intelligence in Medicine 107, 101895, 2020
192020
Informing rubella vaccination strategies in East Java, Indonesia through transmission modelling
Y Wu, J Wood, G Khandaker, C Waddington, T Snelling
Vaccine 34 (46), 5636-5642, 2016
172016
Dynamics of evolutionary rescue in changing environments and the emergence of antibiotic resistance
Y Wu, CA Saddler, F Valckenborgh, MM Tanaka
Journal of Theoretical Biology 340, 222-231, 2014
172014
Identification of the determinants of incomplete vaccination in Australian children
C Lim, GE Currie, CS Waddington, Y Wu, S Setijo, J Leask, JA Marsh, ...
Vaccine: X 1, 100010, 2019
132019
Urinary tract infections in children: building a causal model-based decision support tool for diagnosis with domain knowledge and prospective data
JA Ramsay, S Mascaro, AJ Campbell, DA Foley, AO Mace, P Ingram, ...
BMC Medical Research Methodology 22 (1), 1-17, 2022
112022
The influence of incomplete case ascertainment on measures of vaccine efficacy
Y Wu, JA Marsh, ES McBryde, TL Snelling
Vaccine 36 (21), 2946-2952, 2018
82018
Epidemiological control of drug resistance and compensatory mutation under resistance testing and second-line therapy
CA Saddler, Y Wu, F Valckenborgh, MM Tanaka
Epidemics 5 (4), 164-173, 2013
82013
Estimation of the force of infection and infectious period of skin sores in remote Australian communities using interval-censored data
MJ Lydeamore, PT Campbell, DJ Price, Y Wu, AJ Marcato, W Cuningham, ...
PLoS computational biology 16 (10), e1007838, 2020
72020
Bridging the gaps in test interpretation of SARS-CoV-2 through Bayesian network modelling
Y Wu, D Foley, J Ramsay, O Woodberry, S Mascaro, AE Nicholson, ...
Epidemiology & Infection 149, 2021
62021
A model of population dynamics with complex household structure and mobility: implications for transmission and control of communicable diseases
RH Chisholm, B Crammond, Y Wu, AC Bowen, PT Campbell, SYC Tong, ...
PeerJ 8, e10203, 2020
62020
Predicting the causative pathogen among children with pneumonia using a causal Bayesian network
Y Wu, S Mascaro, M Bhuiyan, P Fathima, AO Mace, MP Nicol, ...
PLoS Comput Biol 19 (3), e1010967, 2023
52023
Burden of congenital rubella syndrome (Crs) in Bangladesh: Systematic review of existing literature and transmission modelling of seroprevalence studies
J Chan, Y Wu, J Wood, M Muhit, MK Mahmood, T Karim, F Moushumi, ...
Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious …, 2020
52020
Modeling COVID-19 disease processes by remote elicitation of causal Bayesian networks from medical experts
S Mascaro, Y Wu, O Woodberry, EP Nyberg, R Pearson, JA Ramsay, ...
BMC Medical Research Methodology 23 (76), 2023
42023
Preferred health outcome states following treatment for pulmonary exacerbations of cystic fibrosis
C McLeod, J Wood, S Mulrennan, S Morey, A Schultz, M Messer, ...
Journal of Cystic Fibrosis, 2022
42022
Novel method to select meaningful outcomes for evaluation in clinical trials
C McLeod, R Norman, J Wood, S Mulrennan, S Morey, A Schultz, ...
BMJ Open Respiratory Research 8 (1), e000877, 2021
42021
Perinatal risk factors associated with skin infection hospitalisation in Western Australian Aboriginal and Non‐Aboriginal children
R Barnes, AC Bowen, R Walker, SYC Tong, J McVernon, PT Campbell, ...
Paediatric and perinatal epidemiology 33 (5), 374-383, 2019
32019
Implications of asymptomatic carriers for infectious disease transmission and control. Royal Soc Open Sci. 2018; 5 (2)
RH Chisholm, PT Campbell, Y Wu, SYC Tong, J McVernon, N Geard
3
The system can't perform the operation now. Try again later.
Articles 1–20